Seromucinous ovarian tumors and endometriosis in reproductive-aged wo
- Authors: Shamarakova M.V.1, Adamyan L.V.2, Asaturova A.V.2, Ezhova L.S.2, Zaitsev N.V.2, Yurova M.V.3, Martirosyan Y.O.3
-
Affiliations:
- Center for Family Planning and Reproduction
- National Medical Research Center of Obstetrics, Gynecology, and Perinatology named after Academician V.I. Kulakov, Ministry of Health of Russia
- I.M. Sechenov First Moscow State Medical University (Sechenov University)
- Issue: No 7 (2018)
- Pages: 84-91
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248319
- DOI: https://doi.org/10.18565/aig.2018.7.84-91
- ID: 248319
Cite item
Abstract
Full Text
About the authors
Marina V. Shamarakova
Center for Family Planning and Reproduction
Email: mshamarakova@yandex.ru
MD, pathologist, Center of family planning and reproduction.
Leila V. Adamyan
National Medical Research Center of Obstetrics, Gynecology, and Perinatology named after Academician V.I. Kulakov, Ministry of Health of Russia
Email: a_asaturova@oparina4.ru
professor, academician of RAMS, head specialist in obstetrics and gynecology, deputy director
Alexandra V. Asaturova
National Medical Research Center of Obstetrics, Gynecology, and Perinatology named after Academician V.I. Kulakov, Ministry of Health of Russia
Email: a_asaturova@oparina4.ru
MD, pathologist, senior scientific assistant
Larisa S. Ezhova
National Medical Research Center of Obstetrics, Gynecology, and Perinatology named after Academician V.I. Kulakov, Ministry of Health of Russia
Email: l_ezhova@oparina4.ru
MD, pathologist, senior scientific assistant
Nikon V. Zaitsev
National Medical Research Center of Obstetrics, Gynecology, and Perinatology named after Academician V.I. Kulakov, Ministry of Health of Russia
Email: a_asaturova@oparina4.ru
MD, pathologist
Mariia V. Yurova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: yurova.m.vl@gmail.com
medical student of the International School «Medicine of Future»
Yana O. Martirosyan
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: marti-yana@yandex.ru
medical student
References
- Франк Г.А., Москвина Л.В., Андреева Ю.Ю. Новая классификация опухолей яичника. Архив патологии. 2015; 77(4): 40-50.
- Matias-Guiu X., Stewart C.J.R. Endometriosis-associated ovarian neoplasia. Pathology. 2018; 50(2): 190-204.
- VerceîîiniP., Vigano P., Somigliana E., Fedele L. Endometriosis: pathogenesis and treatment. Nat. Rev. Endocrinol. 2014; 10(5): 261-75.
- Edwards R.P., Huang X., Vlad A.M. Chronic inflammation in endometriosis and endometriosis-associated ovarian cancer: New roles for the “old” complement pathway. Oncoimmunology. 2015; 4(5): e1002732.
- Briîhante A.V., Augusto K.L., Portela M.C., Sucupira L.C., Oliveira L.A., Pouchaim A.J. et al. Endometriosis and ovarian cancer: an integrative review (endometriosis and ovarian cancer). Asian Pac. J. Cancer Prev. 2017; 18(1): 11-6.
- Saraswat L., Ayansina D., Cooper K.G., Bhattacharya S., Horne A.W., Bhattacharya S. Impact of endometriosis on risk of further gynaecological surgery and cancer: a national cohort study. BJOG. 2018; 125(1): 64-72.
- Mikami Y. Endometriosis-related ovarian neoplasms: pathogenesis and histopathologic features. Diagn. Histopathol. 2014; 20(9): 357-63.
- Davis M., Rauh-Hain J.A., Andrade C., Boruta D.M. 2nd, Schorge J.O., Horowitz N.S. et al. Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary. Gynecol. Oncol. 2014; 132(3): 760-6.
- Anglesio M.S., Papadopoulos N., Ayhan A., Nazeran T.M., NoëM., Horlings H.M. et al. Cancer-associated mutations in endometriosis without cancer. N. Engl. J. Med. 2017; 376(19): 1835-48.
- Chene G., Ouellet V., Rahimi K., Barres V., Provencher D., Mes-Masson A.M. The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis. Int. J. Gynaecol. Obstet. 2015; 130(1): 27-30.
- Rutgers J.K.L. Mullerian mucinous/mixed epithelial (seromucinous) ovarian tumors. AJSP: Rev. Rep. 2016; 21(5): 206-13.
- Miyamoto M., Takano M., Aoyama T., Soyama H., Yoshikawa T., Tsuda H., Furuya K. Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis. J. Gynecol. Oncol. 2018; 29(2): e20.
- Kurman R.J., Shih Ie.M. Seromucinous tumors of the ovary. What's in a name? Int. J. Gynecol. Pathol. 2016; 35(1): 78-81.
- Pearce C.L., Templeman C., Rossing M.A., Lee A., Near A.M., Webb P.M. et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case - control studies. Lancet Oncol. 2012; 13(4): 385-94.
- Wu C.H., Mao T.-L., Vang R. et al. Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A. International Journal of Gynecological Pathology. 2012; 31(4): 297-303.
- Nakamura E., Sato Y., Moriguchi S., Yamashita A. Ovarian seromucinous borderline tumor and clear cell carcinoma: an unusual combination. Case Rep. Obstet. Gynecol. 2015; 2015: 690891.
- Massicot R., Rousseau V., Darwish A.A., Sauvat F. et al. Serous and seromucinous infantile ovarian cystadenomas - a study of 42 cases. Eur. J. Obstet. Gynecol. Reprod. Biol. 2009; 142(1): 64-7.
- Taskinen S., Fagerholm R., Lohi J., Taskinen M. Pediatric ovarian neoplastic tumors: incidence, age at presentation, tumor markers and outcome. Acta Obstet. Gynecol. Scand. 2015; 94(4): 425-9.
- Shappell H.W., Riopel M.A., Smith Sehdev A.E., Ronnett B.M. et al. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas. Am. J. Surg. Pathol. 2002; 26(12): 1529-41.
- Karpathiou G., Chauleur C., Corsini T., Venet M., Habougit C., Honeyman F. et al. Seromucinous ovarian tumor A comparison with the rest of ovarian epithelial tumors. Ann. Diagn. Pathol. 2017; 27: 28-33.
- Rambau P.F., McIntyre J.B., Taylor J., Lee S., Ogilvie T., Sienko A. et al. Morphologic reproducibility, genotyping, and immunohistochemical profiling do not support a category of seromucinous carcinoma of the ovary. Am. J. Surg. Pathol. 2017; 41(5): 685-95.
- Taylor J., McCluggage W.G. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm. Am. J. Surg. Pathol. 2015; 39(7): 983-92.
- McCluggage W.G. Ovarian borderline tumours: a review with comparison of serous and mucinous types. Diagn. Histopathol. 2014; 20(9): 333-50.
- Dubé V., Roy M., Plante M., Renaud M.C. et al. Mucinous ovarian tumors of Mullerian-type: an analysis of 17 cases including borderline tumors and intraepithelial, microinvasive, and invasive carcinomas. Int. J. Gynecol. Pathol. 2005; 24(2): 138-46.